4.4 Stability evaluation Although this short-term assessment was performed as a proof-of-concept rather than a regulatory stability study, it provides important mechanistic insights into how the formulation state of the peptide (dissolved versus suspended) influences the degradation behavior, which is highly relevant for early formulation screening and strategy selection
Many patients are interested in Retatrutide because it may offer enhanced fat-loss support and broader metabolic benefits compared to earlier peptide therapies
If choosing between them, AOD-9604 has the stronger evidence base and regulatory standing
Metabolic Peptides in Cardiovascular Health: How Retatrutide, Tirzepatide, and Survodutide Support Heart Function Compare how GLP-1/GIP/GCGR agonists shape lipids, endothelial function, and inflammation in cardiometabolic models mechanisms and research takeaways
13, 2023 from Canadian Agency for Drugs and Technologies in Health (CADTH)
New clinical data will emerge